Dave Chapman

Title: The Innovations of Dave Chapman

Introduction

Dave Chapman is a notable inventor based in Woking, GB. He has made significant contributions to the field of veterinary science, particularly in the development of vaccines for African Swine Fever (ASF). With a total of 2 patents, his work is crucial in combating this devastating disease that affects swine populations.

Latest Patents

Chapman's latest patents focus on an attenuated African Swine Fever virus vaccine. The first patent provides an attenuated ASF virus that lacks functional versions of specific genes, including the DP148R gene. This invention also details a vaccine comprising such an attenuated virus and its application in preventing ASF. Additionally, it discusses the intranasal administration of the attenuated ASF virus. The second patent similarly outlines an attenuated ASF virus lacking functional versions of multigene-family 360 genes and the DP148R gene, further emphasizing the importance of this vaccine in preventing ASF.

Career Highlights

Dave Chapman is affiliated with The Pirbright Institute, where he conducts his research and development work. His contributions to the field have been recognized for their potential impact on animal health and biosecurity.

Collaborations

Chapman collaborates with esteemed colleagues, including Charles Abrams and Ana-Luisa Reis, who contribute to the research efforts at The Pirbright Institute.

Conclusion

Dave Chapman's innovative work in developing vaccines for African Swine Fever highlights his commitment to improving animal health and preventing disease outbreaks. His patents represent significant advancements in veterinary science and underscore the importance of continued research in this field.